M., & Bisognano, J
Recalls & Warnings December 17, 2020 FTC Crackdown on Six Deceptive CBD Products On December 17, 2020, the FTC announced that it is taking action against six companies for selling CBD products with unsupported and deceptive health claims that they can treat a variety of conditions, including cancer, heart disease, hypertension, Alzheimer's disease, and others
1 GLP-1 medications may enhance that signal, helping support the communication between the gut, brain, and metabolism
While very uncommon with proper administration, it's important to be aware of more serious potential risks, often linked to improper techniques or unreliable products: Allergic Reactions: As with any substance, an allergic reaction (like rashes, hives, or difficulty breathing) is a slim possibility
"Protective effects of methylsulfonylmethane on hemodynamics and oxidative stress in monocrotaline-induced pulmonary hypertensive rats"